166.56
price down icon0.58%   -0.97
after-market Dopo l'orario di chiusura: 166.56
loading

Natera Inc Borsa (NTRA) Ultime notizie

pulisher
Sep 04, 2025

What MACD signals say about Natera Inc.2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Should you wait for a breakout in Natera Inc.Bull Run & Verified Stock Trade Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is Natera Inc. stock reversal real or fakeM&A Rumor & Fast Entry High Yield Stock Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will Natera Inc. rebound enough to break evenWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN

Sep 04, 2025
pulisher
Sep 04, 2025

Detecting price anomalies in Natera Inc. with AIJuly 2025 Trends & Consistent Profit Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Natera Introduces Prenatal Test for Inherited Conditions - Medical Product Outsourcing

Sep 03, 2025
pulisher
Sep 03, 2025

Natera, Inc. shares fall 1.96% intraday after RBC raises price target to $268. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 12:36:09 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Statistical indicators supporting Natera Inc.’s strengthJuly 2025 Trends & Safe Capital Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time breakdown of Natera Inc. stock performanceIndex Update & High Conviction Buy Zone Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Natera Inc. stock retracement – recovery analysisJuly 2025 PostEarnings & Community Verified Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What Natera (NTRA)'s AI-Driven Clinical Trial Integration Means For Shareholders - simplywall.st

Sep 03, 2025
pulisher
Sep 03, 2025

RBC Raises Price Target on Natera to $268 From $255, Keeps Outperform Rating - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Can swing trading help recover from Natera Inc. losses2025 Sector Review & Weekly High Conviction Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Natera Inc. forming a bottoming baseQuarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is a relief rally coming for Natera Inc. holders2025 Sector Review & Stock Portfolio Risk Control - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time pattern detection on Natera Inc. stockStock Surge & AI Forecasted Entry/Exit Points - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Risk vs reward if holding onto Natera Inc.Earnings Overview Report & Low Drawdown Trading Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tick level data insight on Natera Inc. volatilityQuarterly Trade Report & Daily Oversold Stock Bounce Ideas - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Aug Volume: Can Natera Inc. disrupt its industryJuly 2025 Short Interest & Safe Entry Point Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Natera director Chapman sells $459k in shares - Investing.com

Sep 02, 2025
pulisher
Sep 02, 2025

Natera price target raised to $268 from $255 at RBC Capital - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Is Natera Inc. in a bullish channel2025 Key Lessons & Risk Controlled Daily Trade Plans - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

What’s the outlook for Natera Inc.’s sectorTrade Risk Assessment & Fast Entry Momentum Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Natera: A Strategic Growth Play with Cash Flow Resilience in a High-Growth Genomic Testing Market - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Natera: A Compelling Buy Due to Strong Growth and Cash Flow - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Natera: A Buy As Positive Growth And Cashflow Outweigh Unprofitability - Seeking Alpha

Sep 02, 2025
pulisher
Sep 02, 2025

How to interpret RSI for Natera Inc. stockJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

MoFo helps NeoGenomics secure cancer test kit patent infringement win against rival Natera - The Global Legal Post

Sep 02, 2025
pulisher
Sep 02, 2025

Applying Wyckoff theory to Natera Inc. stockExit Point & Weekly Momentum Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What indicators show strength in Natera Inc.2025 Top Gainers & Community Verified Swing Trade Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can machine learning forecast Natera Inc. recoveryJuly 2025 Action & Free Long-Term Investment Growth Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How does Natera Inc. compare to its peers2025 Trade Ideas & Free Expert Verified Stock Movement Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance

Sep 02, 2025
pulisher
Sep 01, 2025

Can Natera Inc. disrupt its industryWeekly Market Outlook & Low Risk High Reward Trade Ideas - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What is Natera Inc. s revenue forecastQuarterly Profit Review & AI Powered Buy/Sell Recommendations - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

NeoGenomics rallies after court win in Natera patent dispute - MSN

Sep 01, 2025
pulisher
Sep 01, 2025

Guidance Update: Should I trade or invest in Natera Inc.Quarterly Trade Review & Comprehensive Market Scan Insights - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Will Natera Inc. benefit from sector rotationJuly 2025 Highlights & Target Return Focused Picks - خودرو بانک

Sep 01, 2025
pulisher
Aug 31, 2025

Risk adjusted return profile for Natera Inc. analyzed2025 Price Action Summary & High Conviction Investment Ideas - Newser

Aug 31, 2025
diagnostics_research LH
$275.23
price up icon 0.51%
diagnostics_research DGX
$180.11
price up icon 0.33%
diagnostics_research MTD
$1,287.79
price up icon 1.51%
diagnostics_research WAT
$299.69
price up icon 3.32%
diagnostics_research IQV
$184.08
price down icon 0.29%
Capitalizzazione:     |  Volume (24 ore):